KYMERA THERAPEUTICS INC (KYMR:NASDAQ)
$115.77 1.78 (1.5615%)
Analysed KYMERA THERAPEUTICS INC (KYMR:NASDAQ) News Sources
Kymera Jumps 17% on Early Enrollment Completion in Skin Disease Study
26-06-2026
yahoo.com
Why Kymera Therapeutics Stock Popped This Week
26-06-2026
fool.com
KYMR Stock Soars 51% YTD on Progress of Atopic Dermatitis Drug
01-07-2026
yahoo.com
How Accelerated KT-621 Trial, Index Additions, and New Chair Will Impact Kymera Therapeutics (KYMR) Investors
03-07-2026
yahoo.com
Kymera Therapeutics (KYMR) Stock Gets Fair Value Bump After KT 621 Timeline Shift
03-07-2026
yahoo.com
Alkami Technology, Diebold Nixdorf, and 3 More Stocks See Action From Activist Investors.
03-07-2026
yahoo.com
Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader
07-07-2026
yahoo.com
Is Kymera (KYMR) the Best Performing American Stock in June 2026?
09-07-2026
yahoo.com
Kymera's CEO Sold $6 Million in Stock After a 170% Run
12-07-2026
fool.com
American Express, Biogen upgraded: Wall Street's top analyst calls
13-07-2026
yahoo.com
What is the current price of KYMERA THERAPEUTICS INC (KYMR:NASDAQ)?
The current price of KYMERA THERAPEUTICS INC (KYMR:NASDAQ) is $115.77.
KYMERA THERAPEUTICS INC (KYMR:NASDAQ) absolute price change since previous trading day?
The absolute price change of KYMERA THERAPEUTICS INC (KYMR:NASDAQ) since the previous trading day is $1.78.
KYMERA THERAPEUTICS INC (KYMR:NASDAQ) percentage price change since previous trading day?
The percentage price change of KYMERA THERAPEUTICS INC (KYMR:NASDAQ) since the previous trading day is 1.5615%.
What is the most recent average sentiment score for KYMERA THERAPEUTICS INC (KYMR:NASDAQ)?
The most recent average sentiment score for KYMERA THERAPEUTICS INC (KYMR:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for KYMERA THERAPEUTICS INC (KYMR:NASDAQ)?
The most recent sentiment for KYMERA THERAPEUTICS INC (KYMR:NASDAQ) is .
SEC-8K** Filing Available For KYMERA THERAPEUTICS INC (KYMR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.